Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
Published on: March 1, 2024
Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report
Miguel Julião1, João Ulrich2, Patrícia Calaveiras2
1Equipa Comunitária de Suporte em Cuidados Paliativos de Sintra, ACES Sintra, Sintra, Portugal migueljuliao@gmail.com.
Objective:
Ketamine is a drug that can effectively treat neuropathic pain by blocking the N-methyl-D-aspartate receptor. It has been studied as a supplement to opioids for cancer pain, but its effectiveness for non-cancer pain is still limited. However, despite its usefulness in managing refractory pain, ketamine is not commonly used for home-based palliative care.
Methods:
A case report of a patient with severe central neuropathic pain who was treated with a subcutaneous continuous infusion of morphine and ketamine at home.
Results:
The introduction of ketamine in the patient's treatment plan effectively controlled pain. Only one possible ketamine side effect was observed and easily treated with pharmacological and non-pharmacological measures.
Conclusions:
We have found success in using subcutaneous continuous infusion of morphine and ketamine to alleviate severe neuropathic pain in a home setting. We also observed a positive impact on the patient's family members' personal, emotional and relational well-being after ketamine was introduced.
Related Concept Videos
Parenteral Anesthetics: Overview
Analgesia and Pain Management

